17
Participants
Start Date
April 27, 2016
Primary Completion Date
July 21, 2020
Study Completion Date
July 21, 2020
Belinostat IV
"Cohort A:~Belinostat 1000mg will be administered once daily on days 1 through 5 of one 21-day cycle via 30-minute IV infusion.~Cohort B:~Belinostat 1000mg will be administered once daily on days 1 through 5 of one 21-day cycle via 30-minute IV infusion.~Cohort C:~Belinostat 750mg will be administered once daily on days 1 through 5 of one 21-day cycle via 30-minute IV infusion."
Gabrail Cancer Center Research, Canton
John Wayne Cancer Institute @ Providence Saint John's Health Center, Santa Monica
The Oncology Institute of Hope and Innovation, Whittier
Lead Sponsor
Collaborators (2)
Axis Clinicals Limited
INDUSTRY
Axis Clinical Trials
OTHER
Acrotech Biopharma Inc.
INDUSTRY